In today’s Pharmaceutical Executive Daily, a new a is expected to evolve in 2026, the FDA rejects AstraZeneca’s application ...

Partnership launched under MTEA to evaluate the potential of Vect-Horus technology to deliver siRNAs into the CNSAssessment ...

Arbutus Biotech (ABUS) heads to a key March Moderna LNP patent trial as imdusiran HBV milestones drive value—get the latest ...

The global demand on agri-food systems continues to grow, necessitating innovative strategies for increasing agricultural ...

Nicole Steinmetz engineers plant virus nanoparticles into versatile drug-delivery platforms. This work expanded into cancer ...

New treatments based on biological molecules like RNA give scientists unprecedented control over how cells function. But ...

The RNA analysis market is poised for significant growth due to rising demand in precision medicine, advancements in NGS technologies, and expanding use of RNA biomarkers in diagnostics and drug ...

Scientists have uncovered a 400-million-year-old genetic secret that gave spiders the ability to produce silk and weave their ...

Benitec Biopharma Inc. reports 100% responder rates for BB-301 with a mid-2026 FDA meeting ahead. See why BNTC stock is upgraded to buy.

Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, announced today that it will report financial results ...

USA News Group News Commentary - Global capital is officially rotating into "Longevity Infrastructure" which is now valued at a massive $27 trillion by 2030[1]. This transition is moving the entire ...

The Swiss Federal Council has confirmed Tanja Zimmermann for a second four-year term as Director of Empa, extending her leadership through May 2030. During her first mandate, Zimmermann strengthened ...